Expression of Human Factor VIII by Splicing between Dimerized AAV Vectors
Open Access
- 30 June 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (6) , 716-722
- https://doi.org/10.1006/mthe.2002.0607
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Adeno-associated virus vectors for gene therapy: more pros than cons?Molecular Medicine Today, 2000
- Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerizationNature Medicine, 2000
- Sustained expression of human factor VIII in mice using a parvovirus-based vectorBlood, 2000
- Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active proteinProceedings of the National Academy of Sciences, 1999
- Persistent expression of canine factor IX in hemophilia B caninesGene Therapy, 1999
- Advances toward Gene Therapy for Hemophilia at the MillenniumHuman Gene Therapy, 1999
- Structural Analysis of Adeno-Associated Virus Transduction Circular IntermediatesVirology, 1999
- The kinetics of rAAV integration in the liverNature Genetics, 1998
- Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1996
- Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIIIBlood, 1993